---
title: "\"Performance\" WAI CHUN BIOTEC's mid-term loss narrowed to 5.94 million yuan"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/277347910.md"
description: "WAI CHUN BIOTEC announced its interim results for the six months ending December 2025, with revenue of HKD 352 million, an increase of 118.7% year-on-year. The loss narrowed from HKD 13.66 million in the same period last year to HKD 5.94 million, with a loss per share of HKD 0.0333. No dividend is declared"
datetime: "2026-03-01T09:32:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277347910.md)
  - [en](https://longbridge.com/en/news/277347910.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277347910.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/277347910.md) | [English](https://longbridge.com/en/news/277347910.md)


# "Performance" WAI CHUN BIOTEC's mid-term loss narrowed to 5.94 million yuan

WAI CHUN BIOTEC (00660.HK) announced its interim results for the six months ending December 2025, with revenue of HKD 352 million, an increase of 118.7% year-on-year. The loss narrowed from HKD 13.66 million in the same period last year to HKD 5.94 million, with a loss per share of HKD 0.0333. No dividend was declared

### 相關股票

- [WAI CHUN BIOTEC (00660.HK)](https://longbridge.com/zh-HK/quote/00660.HK.md)
- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-HK/quote/159849.CN.md)
- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/zh-HK/quote/516500.CN.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-HK/quote/159837.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/zh-HK/quote/516930.CN.md)

## 相關資訊與研究

- [Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines](https://longbridge.com/zh-HK/news/280923090.md)
- [UCB presents new Bimzelx data at AAD](https://longbridge.com/zh-HK/news/280813909.md)
- [Sunho Biologics Flags Audit Delays as Auditor Seeks More Documentation](https://longbridge.com/zh-HK/news/280992698.md)
- [22:54 ETHugel to enter ECM-based injectable market with aesthetic portfolio expansion](https://longbridge.com/zh-HK/news/281291767.md)
- [Junshi Biosciences Chairman Completes RMB100 Million Shareholding Increase](https://longbridge.com/zh-HK/news/281231901.md)